ECM
QTTB icon

ExodusPoint Capital Management’s Q32 Bio QTTB Stock Holding History

ExodusPoint Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-993
Closed -$65K – 2748
2021
Q4 		$65K Sell
993
-381
-28% -$37K ﹤0.01% 2008
2021
Q3 		$195K Buy
1,374
+366
+36% +$46.6K ﹤0.01% 1791
2021
Q2 		$132K Buy
+1,008
New +$126K ﹤0.01% 2090
2020
Q4 		– Sell
-1,563
Closed -$301K – 2451
2020
Q3 		$301K Buy
+1,563
New +$350K 0.01% 1284

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

ExodusPoint Capital Management's QTTB Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 993 shares — an estimated $65K sold.

ExodusPoint Capital Management first reported a position in QTTB in Q3 2020 and held it in 4 quarters. The position peaked at $301K in Q3 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • ExodusPoint Capital Management reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 993 Q32 Bio shares in Q1 2022, an estimated $65K.
  • ExodusPoint Capital Management first reported a position in Q32 Bio in Q3 2020 and held it in 4 quarters.
  • ExodusPoint Capital Management's Q32 Bio position peaked at $301K in Q3 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.